Erector Spinae Plane Block for Postoperative Pain in Percutaneous Nephrolithotomy Patients: a Retrospective Study
Study Details
Study Description
Brief Summary
To evaluate the ability of Erector spina Plane block decrease postoperative pain and analgesia requirements in patients undergoing Percutaneous Nephrolithotomy.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Erector spina Plane block was performed with guided ultrasound at T10 Transverse process level would lead to adequate postoperative analgesia ,in Percutaneous Nephrolithotomy surgeries.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Erector spinae plane block group (ESP) Single- shot ultrasound guided ESP block with 30 ml 0.25% bupivacain at the T10 vertebral level was performed preoperatively to patients in the ESP group (Group I). |
Procedure: Erector Spinae Plane block ( Group I)
ESP Block was performed preoperative to all patients in ESP block group. Patients in all groups were provided with intravenous patient- controlled analgesia device containing morphine for postoperative analgesia.
|
non- blocked Group consists of the patient group without any procedure |
Procedure: non- blocked Group (GROUP II)
This group was received no intervetion. Patients in all groups were provided with intravenous patient- controlled analgesia device containing morphine for postoperative analgesia.
|
Outcome Measures
Primary Outcome Measures
- opioid consumption [24 hours after surgery]
In the recovery room, all patients were given a patient- controlled analgesia device containing morphine 0.5 mg/ml, set to deliver a 1mg bolus dose of morphine with an 10 min lockout time and 10 mg 4 h limit.Total morphine consumption during the 24 hours postoperative period will recorded at 5 times intervals ( 2, 4, 6, 12, 24 hours).
- Verbal analog Pain Scores on rest and movement [24 hours after surgery]
A Research assistant, blinded to the group allocation, interviewed patients and collected data at 5 times intervals ( 2, 4, 6, 12, 24, hours) in the 24 hours postoperatively. Patients were asked to rate their pain using verbal analog scale, where 0= no pain and 10= worst pain possible.
Secondary Outcome Measures
- Demographic data [24 hours after surgery]
Age, BMI, ASA, Duration of surgery was recorded.
- incidences of adverse effects (like nausea and vomiting) [24 hours after surgery]
incidences of nausea and vomiting during the 24 hours postoperative period was recorded recorded at 5 times intervals ( 2, 4, 6, 12, 24 hours).
Eligibility Criteria
Criteria
Inclusion Criteria:
- ASA I- ASA II Patients
Exclusion Criteria:
-
history of allergy to the study medication
-
refusal to participate
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Sibel Seçkin Pehlivan | Kayseri | Talas | Turkey | 38039 |
Sponsors and Collaborators
- TC Erciyes University
Investigators
- Study Director: Sibel Pehlivan, TC Erciyes University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2019/881